Hidetomo Himuro
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Gut microbiome functional pathways outperform taxonomic profiles in predicting immune checkpoint inhibitor response in non-small cell lung cancer: an interpretable machine learning approach with SHAP.
Journal: Frontiers in immunology
Published: March 17, 2026
Machine learning-based insights into circulating autoantibody dynamics and treatment outcomes in patients with NSCLC receiving immune checkpoint inhibitors.
Journal: Frontiers in immunology
Published: July 15, 2025
Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer.
Journal: Frontiers in immunology
Published: November 01, 2024
Improvement in the function of self-activating chimeric antigen receptor by replacing the linker sequence.
Journal: Frontiers in immunology
Published: September 27, 2024
Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Journal: Biomedicines
Published: July 04, 2024
Recent Trends and Potential of Radiotherapy in the Treatment of Anaplastic Thyroid Cancer.
Journal: Biomedicines
Published: April 26, 2024
Enhancing Mass spectrometry-based tumor immunopeptide identification: machine learning filter leveraging HLA binding affinity, aliphatic index and retention time deviation.
Journal: Computational and structural biotechnology journal
Published: November 02, 2023
Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors.
Journal: Frontiers in cell and developmental biology
Published: October 20, 2023
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
Journal: International journal of clinical oncology
Published: September 28, 2023
Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma.
Journal: Frontiers in pharmacology
Published: July 31, 2023
Novel chimeric antigen receptor-expressing T cells targeting the malignant mesothelioma-specific antigen sialylated HEG1.
Journal: International journal of cancer
Published: June 12, 2023
Machine learning for prediction of immunotherapeutic outcome in non-small-cell lung cancer based on circulating cytokine signatures.
Journal: Journal for immunotherapy of cancer
Published: June 11, 2023
Last Updated: 09/26/2026